Cargando…

Is there a role for consolidative radiotherapy in the treatment of aggressive and localized Non-Hodgkin Lymphoma? A systematic review with meta-analysis

BACKGROUND: Chemotherapy is the mainstay of non-Hodgkin lymphoma (NHL) treatment. Based on expert opinion, the use of radiotherapy (RT) is currently preferred in some institutions as consolidative treatment for patients with localized disease. The lack of conclusive data coming from conflicting stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	dos Santos, Lucas Vieira, Lima, JoãoPaulodaSilveiraNogueira, Lima, Carmen Sílvia Passos, Sasse, Emma Chen, Sasse, André Deeke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464777/ https://www.ncbi.nlm.nih.gov/pubmed/22793998 http://dx.doi.org/10.1186/1471-2407-12-288

Ejemplares similares

Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Lima, André Bacellar Costa, et al.
Publicado: (2011)

Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
por: Macedo, Ligia Traldi, et al.
Publicado: (2012)

Adjuvant therapy for locally advanced renal cell cancer: A systematic review with meta-analysis
por: Scherr, Adolfo JO, et al.
Publicado: (2011)

Consolidation radiotherapy for advanced-stage aggressive B-cell non-Hodgkin lymphoma: A systematic review and meta-analysis
por: Yap, Ernie, et al.
Publicado: (2017)

Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma
por: Medici, Carolina Trindade Mello, et al.
Publicado: (2020)

Cost-effectiveness of cetuximab and panitumumab for chemotherapy-refractory metastatic colorectal cancer
por: Carvalho, Adriana Camargo, et al.
Publicado: (2017)

Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk non-metastatic prostate cancer: A systematic review and meta-analysis
por: Leal, Frederico, et al.
Publicado: (2015)

Hodgkin Lymphoma—Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients
por: Momotow, Jesko, et al.
Publicado: (2021)

Antipodal universes in the topology H$^{3}$ x R and S$^{3}$ x R
por: Deeke Sasse, F, et al.
Publicado: (1993)

Androgenic suppression combined with radiotherapy for the treatment of prostate adenocarcinoma: a systematic review
por: Sasse, André D, et al.
Publicado: (2012)

Hodgkin’s lymphoma: post- autologous transplantation consolidation therapy
por: Merli, Francesco, et al.
Publicado: (2020)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy
por: Rapoport, AP, et al.
Publicado: (2002)

Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphoma
por: Saifi, Omran, et al.
Publicado: (2023)

(18)F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer
por: Brito, Ana E., et al.
Publicado: (2017)

Consolidative mediastinal radiotherapy for advanced-stage classical Hodgkin lymphoma with bulky disease in patients who achieve complete response after chemotherapy in PET-CT era
por: Atanazio, Marcelo Junqueira, et al.
Publicado: (2022)

Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
por: Zhou, Minglong, et al.
Publicado: (2008)

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma
por: Yeoh, Kheng-Wei, et al.
Publicado: (2011)

Beneficial effect of consolidative radiotherapy for patients with lymphoma and skeletal involvement
por: Xiao, Yin, et al.
Publicado: (2019)

Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma
por: Spicer, J, et al.
Publicado: (2004)

PET/CT and brown fat in the evaluation of treatment response in Hodgkin lymphoma
por: Pessanha, Laís Bastos, et al.
Publicado: (2015)

Letter to the editor: New metrics to monitor progress towards global HIV targets: using the estimated number of undiagnosed HIV-infected individuals as denominator
por: Sasse, André
Publicado: (2016)

The Evolving Role of Radiotherapy in Early Stage Hodgkin’s Lymphoma
por: Ricardi, Umberto, et al.
Publicado: (2014)

Expanded neuromuscular morbidity in Hodgkin lymphoma after radiotherapy
por: Oishi, Tatsuya, et al.
Publicado: (2020)

Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Alessa, Mohammed A., et al.
Publicado: (2015)

Extranodal large B-cell type aggressive non-Hodgkin's lymphoma
por: Batra, Ranmeet, et al.
Publicado: (2014)

Aggressive squamous cell carcinoma as a harbinger of non-Hodgkin lymphoma
por: Callaghan, Daniel J., et al.
Publicado: (2018)

Non-Hodgkin lymphoma mimicking cholangiocarcinoma
por: Mendes, Gustavo Gomes, et al.
Publicado: (2019)

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
por: Momotow, Jesko, et al.
Publicado: (2019)

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
por: Lynch, Ryan C., et al.
Publicado: (2022)

Cancer-Related Fatigue and Muscle Quality in Hodgkin’s Lymphoma Survivors
por: de Lima, Filipe Dinato, et al.
Publicado: (2017)

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma
por: Kang, Ka-Won, et al.
Publicado: (2018)

Role of Consolidative Radiation Therapy After Autologous Hematopoietic Cell Transplantation for the Treatment of Relapsed or Refractory Hodgkin Lymphoma
por: Wilke, Christopher, et al.
Publicado: (2017)

Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?
por: Hackshaw, A, et al.
Publicado: (2004)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy
por: Schmitz, Christine, et al.
Publicado: (2020)

Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin’s Lymphomas
por: Ramadan, Safaa, et al.
Publicado: (2021)

The Benefit of Telemonitoring in the Prevention of Septic Shock in a Patient with Aggressive Non-Hodgkin’s Lymphoma
por: Dudová, Lucie, et al.
Publicado: (2023)

PB2064: RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS TREATED WITH RADIOTHERAPY
por: Kallel, F., et al.
Publicado: (2022)

Radiotherapy for Non-Hodgkin’s lymphoma with cardiac infiltration: A case report
por: Wang, Weifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tse883vtslup57cm60bq5shu1q